The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Chugai Pharma; Johnson & Johnson; Stryker
Consulting or Advisory Role - AstraZeneca
A multicenter randomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF trial): Analysis of overall survival.
 
Masatoshi Kudo
Honoraria - Bayer; Bristol-Myers Squibb Japan; EA Pharma; Eisai; Lilly Japan; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; MSD; Ono Pharmaceutical; Roche
Research Funding - Abbvie (Inst); EA Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); Ono Pharmaceutical; Otsuka (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Kiyoshi Hasegawa
Honoraria - Bayer Yakuhin; Chugai Pharma; Eisai; Taiho Pharmaceutical; Takeda
Research Funding - Fujifilm (Inst); Nipro Corporation (Inst); Shimadzu (Inst)
 
Yoshikuni Kawaguchi
Honoraria - Otsuka
Consulting or Advisory Role - ConMed
 
Tadatoshi Takayama
No Relationships to Disclose
 
Namiki Izumi
No Relationships to Disclose
 
Naoki Yamanaka
No Relationships to Disclose
 
Mitsuo Shimada
Research Funding - Abbvie (Inst); Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TSUMURA & CO. (Inst)
 
Masahumi Inomata
No Relationships to Disclose
 
Shuichi Kaneko
Stock and Other Ownership Interests - PeptiDream
Honoraria - Bayer; Eisai; Lilly; MSD; Ono Pharmaceutical; Takeda
Consulting or Advisory Role - Bayer; Eisai; MSD
 
Hideo Baba
Honoraria - Taiho Pharmaceutical
Research Funding - Asahi Kasei; Chugai Pharma (Inst); Johnson & Johnson K.K.; Lilly Japan; MSD K.K (Inst); Shin Nippon Biomedical (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Kazuhiko Koike
Speakers' Bureau - Bayer; Eisai; MSD; Takeda
Research Funding - Chugai Pharma; Eisai; Takeda
 
Masao Omata
No Relationships to Disclose
 
Masatoshi Makuuchi
No Relationships to Disclose
 
Yutaka Matsuyama
No Relationships to Disclose
 
Norihiro Kokudo
No Relationships to Disclose